Thoracic ultrasound has advanced from a pleural adjunct to a versatile bedside modality for lung parenchyma assessment. Evidence built over the last decade shows strong diagnostic performance across common respiratory conditions and increasing inclusion in clinical statements and practice guidance. As a radiation-free technique that can be repeated at the point of care, it supports rapid triage, monitoring and procedure planning where timely decisions matter. Use widened during the COVID-19 pandemic and has persisted in acute and chronic pathways in emergency departments, intensive care units and outpatient services. While centrally located or non-subpleural disease remains challenging, clearer scanning protocols, characteristic sonomorphology and structured training are improving consistency in acquisition and interpretation.
Diagnostic Applications and Patterns
In community-acquired pneumonia, thoracic ultrasound demonstrates high accuracy. A multicentre cohort reported sensitivity of 93.4% and specificity of 97.7%, with pooled estimates in larger syntheses near 92% and 94%. Sonographic consolidation, often with air bronchograms, is typical, and concurrent pleural effusion is identified more frequently than with chest x-ray, which can accelerate drainage decisions. In viral pneumonia, small subpleural consolidations with diffuse B-lines predominate over posterior and lateral zones. During COVID-19, pleural line irregularity, heterogeneous B-lines and variable consolidations were characteristic. Pooled diagnostic sensitivity for COVID-19 approached 89% with moderate specificity, broadly comparable to computed tomography and higher sensitivity than chest x-ray for rule-out.
Recognition of acute respiratory distress syndrome reflects heterogeneous B-lines with non-gravity-dependent distribution, pleural line abnormalities and consolidations. Notably, the 2024 global definition includes thoracic ultrasound among accepted chest imaging modalities. Scoring of zonal patterns can assist classification into focal and non-focal phenotypes. In suspected pulmonary embolism, parenchymal changes from infarction or atelectasis appear as pleural-based subpleural lesions. One or more such lesions yield good sensitivity, while two or more increase specificity to about 96%, underscoring value in integrated protocols with cardiac and deep venous ultrasound where appropriate.
For interstitial lung disease, diffuse bilateral B-lines with pleural irregularity suggest fibrotic phenotypes. In connective tissue disease-related interstitial lung disease, pooled sensitivity and specificity were approximately 86% and 84%. In cardiogenic or non-cardiogenic pulmonary oedema, multiple B-lines in several zones are typical, most pronounced in dependent regions. Comparative analyses indicate thoracic ultrasound provides higher diagnostic yield than chest x-ray as an initial test in decompensated heart failure, with pooled sensitivity around the high eighties and specificity near 90%. Serial assessments have shown utility for tracking extravascular lung water, with randomised studies supporting monitoring applications.
Protocols, Equipment and Limits
Reliable interpretation rests on consistent technique. Validated scanning schemes, such as a 14-zone protocol spanning anterior, lateral and posterior regions, help standardise acquisition and reporting. Basic assessment can be delivered with cart-based systems using a low-frequency curvilinear transducer for general evaluation and a high-frequency linear transducer for pleural line and subpleural detail. Dedicated lung presets increasingly support artefact-aware imaging, although operators should understand how settings influence visibility of A-lines and B-lines. Positioning matters: seated examination improves access to posterior zones, while supine protocols have been validated for critically ill patients.
Must Read: AI Triage Cuts Workload in Low-Dose Lung Screening
Normal sonomorphology features a bright pleural line with synchronous lung sliding and horizontal A-lines, pathology is inferred from pleural line abnormalities, vertical B-line artefacts or direct visualisation of subpleural consolidations. Important limits arise from the air-filled lung. Diseases without increased subpleural density, such as chronic obstructive disease, emphysema or cystic disorders, and central lesions not abutting the pleura, are beyond ultrasound resolution. Conversely, conditions that increase subpleural density diffusely, including oedema, interstitial lung disease and viral pneumonias, and those creating nonaerated tissue such as bacterial pneumonia, atelectasis or infarction, are well suited to ultrasound evaluation.
Evolving Uses and Training
Point-of-care pathways in emergency and critical care illustrate practical impact. When integrated with cardiac and venous scans in the emergency department, ultrasound improved early diagnostic accuracy and increased the proportion of patients receiving appropriate treatment within hours of admission. In intensive care, bedside imaging avoids transport of unstable patients and supports monitoring of aeration, ventilator-associated pneumonia, ventilatory strategies and fluid management. As protocols mature, trials continue to refine where serial scoring and multimodal integration most effectively alter clinical decisions.
Advanced techniques may further extend capability. Contrast-enhanced ultrasound helps delineate abscesses, guide sampling and improve biopsy yield by identifying malignant vascular patterns and necrotic areas within lesions. Elastography shows promise for assessing tissue stiffness in subpleural consolidations, interstitial lung disease and pleural effusions, though heterogeneous methods and data currently preclude routine adoption. With broader scope comes the need for structured education. Where local or national requirements exist, they should be followed, with recognised programmes available when formal pathways are lacking. Competence should cover appropriate indication selection, protocol execution, pattern recognition and integration with clinical context.
Thoracic ultrasound has matured into a clinically valuable modality for lung parenchyma, combining bedside accessibility with robust diagnostic performance across pneumonia, acute respiratory distress syndrome, pulmonary embolism, interstitial lung disease and pulmonary oedema. Standardised protocols, awareness of artefact-based interpretation and recognition of technical limits enable consistent use across emergency and intensive care environments. Emerging applications, including contrast enhancement and serial assessment of extravascular lung water, signal potential for further gains in accuracy and utility, aligning with the needs of services seeking safer, faster and repeatable respiratory imaging at the point of care.
Source: British Journal of Radiology
Image Credit: iStock
